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Background: Staphylococcus aureus has been recognized as an important pathogen associated
with inpatients and community infections. Community-acquired methicillin-resistant S.
aureus (CA-MRSA) infections commonly present as skin and soft-tissue infections (SSTIs).
Treatment often includes incision and drainage with or without adjunctive antibiotics.
Objectives: This study aimed to identify CA-MRSA infections both phenotypically and geno-
typically, to determine their spectrum of antibiotic resistance, and to establish the best
scheme for molecular distinction between hospital-acquired MRSA (HA-MRSA) and CA-
MRSA by staphylococcal cassette chromosome mec (SCCmec) typing and detection of Panton
Valentine leukocidin (PVL).
Materials: 50 swabs, from skin and soft tissue of infected lesions of outpatients attending
the dermatology department of the Medical School, Alexandria University, were collected.
Additionally, a nasal swab was taken from every participant.
Methods: Collection of swabs from the infected skin and soft tissues, followed by laboratory
testing to phenotypically and genotypically identify MRSA. Also, nasal swabs were taken
from every patient to identify MRSA colonization.
Results: Staphylococcus aureus strains were identiﬁed in 38 (76%) of the 50 clinical isolates. 18
(47.37%) out of the 38 S. aureus strains were resistant to oxacillin and cefoxitin discs, were
penicillin binding protein 2a (PBP2a) producers, and were initially diagnosed as MRSA. All of
the 18 strains were deﬁnitively diagnosed as MRSA by mecA gene detection using real timePCR, while only six (33.33%) strains were PVL positive. Using the sets of primers of Zhang
of the 18 CA-MRSA strains were SCCmec type V, and one (5.56%) waset al.: nine (50%) outSCCmec type IVc. Then, using the set of primers by Oliveira et al., two (25%) out of the eight
untypable MRSA strains were found to be SCCmec type IV, and six (75%) remained untypable.
∗ Corresponding author at: Department of Dermatology, Venereology and Andrology, Medical School, Alexandria University, Azarita,
Alexandria 23114, Egypt.
E-mail address: nana dermatology@yahoo.com (N. Sobhy).
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Conclusions: CA-MRSA must be considered when treating skin and soft tissue infections,
especially in developing countries. Empirical use of agents active against CA-MRSA is warr-
anted for patients presenting with serious SSTIs.
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mong staphylococcal species, Staphylococcus aureus is the
ost pathogenic organism. The spread of antibiotic resis-
ance among strains of S. aureus is a major concern in
he treatment of staphylococcal infections. It is well known
hat the organism acquires resistance soon after the intro-
uction of new antibiotics. Methicillin was developed in
960 for the treatment of multi-drug resistant S. aureus.
owever, in the same year, methicillin-resistant S. aureus
MRSA) was discovered.1–3MRSA infections have usually been
ssociated with exposure to health care settings, but they
ave recently been identiﬁed in people without traditional
isk factors. These infections have been called community-
cquired or community-associated MRSA (CA-MRSA).1 Most
ases have been associated with skin and soft-tissue infection
SSTI), and have been reported among selected populations,
ncluding correctional facility inmates, homosexual men, and
thletes.4–6
CA-MRSA was ﬁrst described in the 1980s in drug users
nd in the 1990s the epidemic emerged in persons without
ntecedent healthcare exposure. It became a major con-
ern worldwide. CA-MRSA is responsible for a wide array of
nfections from superﬁcial skin infections to life-threatening
iseases.5,7
The accurate and early determination of methicillin resis-
ance is of key importance in the prognosis of infections
aused by S. aureus. Althoughmultiplemethods of detection of
his resistance have been developed, identiﬁcation of themecA
ene is themost reliablemethod of detectingMRSA isolates.7,8
Asymptomatic carriers usually act as reservoirs for infec-
ion during outbreaks caused by S. aureus,9,10 and colonization
s a predisposing factor for infection with CA-MRSA.11,12
CA-MRSA has been reported to carry the loci for Panton-
alentine leukocidin (PVL), in high frequency in association
ith the type IV and type V SCCmec.13–15 PVL is a virulance
eterminant factor for MRSA.
The aim of this study was to identify CA-MRSA infections
oth phenotypically and genotypically, to determine their
pectrum of antibiotic resistance, and to establish the best
ethod for molecular distinction between hospital acquired
RSA (HA-MRSA) and CA-MRSA by SCCmec typing and detec-
ion of PVL.
ethods
atients
© 20ifty patients suffering from skin and or soft tissues infections
ere chosen according to the criteria of the Centers for Dis-
ase Control and Prevention (CDC), which deﬁned CA-MRSA
nfection as: identiﬁcation of MRSA in a patient with signsand symptoms of infection, either in the outpatient setting or
within 48hours after admission to a hospital, with no history
of MRSA infection or colonization; no history of admission to
a hospital or a nursing home during the previous year; and
absence of dialysis, surgery, permanent indwelling catheters,
or medical devices that pass through the skin to the body.16–18
All the patients attended the dermatology department of
the Faculty of Medicine, Alexandria University.
Demographic data of the patients
Age: from 5 to 40 years.
Gender: 40 males and 10 females.
Occupations: 10 school children, 30military personnel (one
family member of military personnel); 10 patients were adults
working in bad hygiene and crowded conditions.
Residence: 30 patients fromovercrowded bad hygienic con-
dition from rural area, 20 patients from urban area. Type
of skin lesions: eight patients had impetigo, ten had boils,
seven had carbuncle, three had infected pediculosis, seven
had infected scabies, ﬁve had infected tinea capitis, and ten
had infected wounds. Sites of skin lesions: eight on back of
neck, sevenon the groin, ﬁve on thebuttock, ﬁve on the armpit,
four on the beard area of males, three on the scalp, eight on
the abdomen, four on the back, three on the leg, and three on
the foot.
Method
Swabs from infected skin and soft tissue lesionswere taken by
inserting a swab into the lesion and rotating it for a count of
ﬁve seconds. The swab was then placed carefully into its con-
tainer, labeled as skin or soft tissue, and patient details were
completed clearly before being inserted into a microbiology
form.
Nasal swabs were taken by inserting a swab into a nostril,
and rotating it for a count of ﬁve seconds before repeating
the process with the other nostril. It is not necessary to insert
the swab very far into the nasal passage. The swab was then
placed carefully into its container, labeled “nasal swab”, and
patient details were completed clearly before being inserted
into a microbiology form.
The swabs were obtained after the signing of an informed
consent (in the case of children, their parents signed the
informed consent). The study was approved by the Research
Ethics Committee of the Alexandria Faculty of Medicine.
Identiﬁcation of staphylococcal isolates
All samples were inoculated on blood agar and MacConkey
sevier Editora Ltda.   Este é um artigo Open Access sob a licença de CC BY-NC-NDagar plates. Staphylococcal isolates were identiﬁed by their
colonial appearance. Colonies suspected as staphylococci
were Gram-stained and tested by catalase, oxidase, slide coag-
ulase, and tube coagulase test.19,20
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Antibiotic susceptibility testing
Susceptibility proﬁle of staphylococci was determined by disc
diffusion method including oxacillin and cefoxitin discs.21,22
Detection of penicillin binding protein 2a (PBP2a) latex
agglutination test
The PBP2a latex agglutination test was performed to detect
the presence of PBP2a, which is responsible for methicillin
resistance.23
Polymerase chain reaction (PCR) staphylococcal DNA
extraction
Using SYBR Green 1 technique.24–26
Procedures:
1. Staphylococcal DNA extraction: staphylococcal isolates
were subcultured overnight at 37◦ C on blood agar media.
Some colonies were emulsiﬁed in 200L sterile distilled
water to produce a heavy suspension. The bacterial sus-
pension was heated at 100 ◦C for 15min. The suspension
was then centrifuged at 14.000 rpm (Hettich zentrifugen)
for 5min.
2. Ampliﬁcation protocol: each PCR tube contained the fol-
lowing:
 12.5LSYBRGreenuniversal PCRmastermix 2-fold con-
centrate were added to the reaction mixture.
 6.5L PCR grade water, bringing the reaction volume to
25 (L.
 0.5L forward primer.
 0.5L reverse primer.
 5L DNA extract.
A negative control was prepared by adding the same con-
tents to a tube with water instead of extract.3. The tubes were placed in the thermal cycler for ampliﬁca-
tion according to the following thermal proﬁle (Fig. 1).
Real time PCR was used to determine the occurrence of
PVL as a virulence factor in CA-MRSA. The presence of PVL
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Fig. 1 – Thermal proﬁle of ampliﬁcation of mecA using SYBR12;16(5):426–431
genes in selected MRSA isolates was assessed by using PCR
as previously described by Lina et al.27
Characterization and concomitant subtyping of
staphylococcal cassette chromosome mec types
The characterizationand subtypingwereperformedaccording
to Zhang et al.,26 and rapid identiﬁcation of structural types
and variants of the mec element in MRSA were performed
according to Oliveira et al.28
Results
S. aureus was identiﬁed by slide and tube coagulase tests in
38 (76%) out of the 50 clinical isolates. 29 (76.31%) out of the
38 S. aureus isolates were mannitol fermenters. The antibiotic
sensitivity of CA-MRSA ranged from 22.22% for ceftriaxone to
94.44% for imipenem and rifampicin. 18 (47.37%) out of the 38
S. aureus isolates were resistant to oxacillin and cefoxitin discs
and were initially diagnosed as MRSA.
All the 18 strains were ﬁnally diagnosed as MRSA by detec-
tion of mecA gene using real time PCR using SYBR Green 1
technique. All 18 MRSA strains (100%) were PBP2a producer.
Out of the 18 CA-MRSA, ten were typable by the set of primers
by Zhang et al.: nine (50%) belonged to SCCmec type V, and one
(5.56%) to SCCmec type IVc.
Using Oliveira et al.28 set of primers, two (25%) of the eight
untypableMRSA strainswere found to be type IV, and six (75%)
remained untypable. Out of the 18 MRSA isolates, only six
(33.33) were PVL positive.
Regarding skin lesions CA-MRSA isolates were recovered
from abscess, furuncles and carbuncles, and from infected
surgical wounds. Regarding nasal swabs: nasal swabs were
positive for CA-MRSA in all cases infected with CA-MRSA.
Regarding the site of the lesions CA-MRSA isolateswere recov-
ered from back of neck, groin, buttock, armpit, and beard area
of males. Most of cases diagnosed as CA-MRSA came from
overcrowded and rural areas.
al profile
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Green 1 technique followed by melting curve analysis.
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iscussion
n the present study, a total of 50 swabs were collected from
kin and soft tissue of infected lesions in outpatients attend-
ng the dermatology department of the Faculty of Medicine,
lexandria University, from October 2009 to December 2010.
asal swabs were also taken from every participant.
In the present study, 50 isolates were collected from differ-
nt skin infections. 42 (84%) were identiﬁed as Staphylococcus
pp., four (8%) as Streptococci spp., and four (8%) as Proteus
pp. 38 (90.48%) out of the 42 staphylococci were diagnosed
s S. aureus. Similar results were found by Abdallah et al.,29
ohanty et al.,21 and Moet et al.30
The accurate and early determination of methicillin resis-
ance is of key importance in the prognosis of infections
aused by S. aureus. Although multiple methods of detection
f this resistance have been developed, they are often too slow
r not sufﬁciently sensitive or speciﬁc to ensure appropriate
reatment of the MRSA-infected patients.19,20
Identiﬁcation of the mecA gene is the most reliable method
or detecting MRSA isolates; however, not all laboratories can
nclude molecular biology techniques in their routine clinical
ractice. For this reason, it is essential to evaluate phenotypic
echniques for MRSA detection in a rapid and accurate man-
er, in order to ensure correct antibiotic treatment and to avoid
he spread of MRSA isolates in the environment.19,20
Methods based on disc diffusion, as well as microdilution
ith oxacillin, are often not entirely reliable at detecting some
trains that harbor the mecA gene.31
In the present study, out of the 38 S. aureus strains isolated
rom the different skin lesions, 18 (47.37%) were positive for
he mecA gene. All strains were resistant to both cefoxitin disc
nd oxacillin disc (sensitivity 100%).
Swenson et al. assessed cefoxitin disc diffusion for pre-
icting mecA-mediated oxacillin resistance in S. aureus and
ound that the sensitivity and speciﬁcity of the test were 98%
nd 100%, respectively, for S. aureus. They demonstrated that
xacillin MIC, oxacillin disc diffusion tests, and cefoxitin disc
iffusion are essentially equivalent in performance for both
ensitivity and speciﬁcity.32
Velasco et al. found that three (5.9%) out of the 51 clini-
al strains that were positive for the mecA gene yielded false
egative results with the oxacillin disc diffusion, (sensitivity
4.1%). They explained the lower sensitivity by the absence of,
r reduced expression of, the mecA-encoded protein, PBP2a.
he results of their study conﬁrmed that antibiotics that are
ble to induce the expression of methicillin resistance, such
s cefoxitin, are the most appropriate for detecting MRSA
solates, as all mecA-positive isolates were detected with the
efoxitin disc, with a sensitivity of 100%.31
Identiﬁcation of MRSA is more accurate either by directly
etecting the gene encoding the methicillin resistance deter-
inant (mecA) or its product (PBP2a).22,23 This is in accordance
ith Cavassini et al.33 and Sakoula et al.34 In this study, the 18
RSA strains were PBP2a producers.
In the present study, 27.78% of the strains were found to beesistant to gentamycin, 11.11% were found to be resistant to
o-trimoxazole, and 22.2% to oﬂoxacin.2;16(5):426–431 429
Both CA-MRSA and HA-MRSA are resistant to tradi-
tional anti-staphylococcal beta-lactam antibiotics. CA-MRSA
isolates tend to be more susceptible to other antibiotics
(including sulfa drugs and tetracyclines) than HA-MRSA iso-
lates, and their narrow spectrum of resistance is solely
due to determinants harboured on genetic elements present
on the SCCmec. HA-MRSA may contain resistance elements
for numerous antibiotic classes, including macrolides, lin-
cosamides, aminoglycosides, ﬂuoroquinolones, tetracyclines,
and sulfonamides.7
Kaplan noted that most of the CA-MRSA isolates are
susceptible to vancomycin, gentamycin, rifampicin, co-
trimoxazole, clindamycin, doxycycline, and linezolid.35
In the present study, 100% of the CA-MRSA isolates were
resistant to fusidic acid. The prolonged use of fusidic acid as
topical monotherapy for chronic skin conditions appears to
have resulted in the emergence of resistance among S. aureus
in some countries, making this agent less active both for topi-
cal and systemic therapy. Resistance to this antibiotic has also
been detected in community-acquired methicilin-susceptible
S. aureus (CA-MSSA) strains, as well as CA-MRSA strains in
other European countries.36
SCCmec typing is one of the most important molecular
tools available for understanding the epidemiology and clonal
strain relatedness of MRSA, particularly with the emerging
outbreaks of CA-MRSA occurring on a worldwide basis.19,20
In the present study, the mec gene complex of the 18 MRSA
strains could not be classiﬁed as class A or B using Zhang
et al.26. Conversely, by using Zhang et al. speciﬁc primers for
identiﬁcation of SCCmec types and sub-types I, II, III, IVa, IVb,
IVc, IVd, and V, nine (50%) of the 18 MRSA strains were classi-
ﬁed as SCCmec type V, one (5.56%) was classiﬁed as type IVc,
and eight (44.44%) were untypable.
In the present study, using Oliveira et al. primers, two out
of the eight untypable MRSA strains were classiﬁed as SCCmec
type IV, while six remained untypable.
Similar results were reported by Hanssen et al., who found
strains that did not ﬁt into the SCCmec typing, which were
designated as possibly new SCCmec types.37
In the present study, three (16.67%) out of the 18 CA-MRSA
strains were classiﬁed as SCCmec type IV using the schemes of
Zhang et al. and those of Oliveira et al.26,28
There has been much interest in PVL, due to its involve-
ment in severe disease among children and young adults with
no known exposure to healthcare establishments. CA-MRSA
has been reported to carry the loci for PVL at high frequency,
and to be associated with the SCCmec type IV.27
In the present study, six (33.33%) out of the 18 MRSA iso-
lates were PVL positive while among the 20 MSSA isolates
only three (15%) were PVL positive. Among the six PVL pos-
itive MRSA isolates, three were SCCmecV, one SCCmecIV, and
two were untypable.
In the present study, PVL positivity was not related to
SCCmec typing since one third of the PVL positive strains were
untypable while only 33.3% of each of type IV and V were PVL
positive.However, ﬁve of the PVL positive strains were sensitive
to the majority of the tested antibiotics, indicating their
community-acquired origin.
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More recently, cases of community-acquired pneumonia
due to PVL-positive S. aureus have been reported in France,
Sweden, the Netherlands, and the United Kingdom. In addi-
tion, the PVL genes have been identiﬁed as a stable marker of
CA-MRSA strains worldwide.27,38
When isolates were categorized according to type of
staphylococcal infection, the PVL genes were strongly asso-
ciated with skin and soft tissue infections, such as abscesses,
skin lesions, and boils (furuncles).27,38
Conversely, PVL genes were seldom found in the general
S. aureus population, a result in concordance with a Swedish
study that showeda lowprevalence of PVL among S. aureus iso-
lates from patients with primary skin infections, pneumonia,
and staphylococcal bacteremia.27,38
In the present study, the combination of SCCmec typing
and PVL positivity was not sufﬁcient to identify all CA-MRSA
isolates, due to the absence of PVL among several CA-MRSA
strains, and due to the presence of untypable MRSA.
The combination of phenotypic characteristics in conjunc-
tionwith certain antibiograms is useful to a degree, but further
work is required to ﬁnd a reliable marker or combination of
markers to facilitate the recognition of CA-MRSA. It appears
that, to date, there is no unique marker or combination of
markers that can substitute for descriptive epidemiology in
the recognition of CA-MRSA.
The nasal swab was positive for CA-MRSA in every patient
who was positive for CA-MRSA skin and soft tissue infection,
demonstrating that colonization is a predisposing factor for
infection with CA-MRSA.
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